021-51111890
购物车（）
sales@molnova.cn
Vorolanib
CAS No. 1013920-15-4
Vorolanib ( CM082,X-82 )
产品货号. M21932 CAS No. 1013920-15-4
Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2001 | 有现货 |
|
| 10MG | ￥3216 | 有现货 |
|
| 25MG | ￥5370 | 有现货 |
|
| 50MG | ￥7655 | 有现货 |
|
| 100MG | ￥10368 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Vorolanib
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.
-
产品描述Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.
-
同义词CM082,X-82
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR;PDGFR
-
研究领域Urinary system/Cancer
-
适应症Renal Cell Cancer Metastatic
化学信息
-
CAS Number1013920-15-4
-
分子量439.48
-
分子式C23H26FN5O3
-
纯度>98% (HPLC)
-
溶解度DMSO:22 mg/ml(50.06 mM; Need ultrasonic)
-
SMILESCN(C)C(=O)N1CC[C@@H](C1)NC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr;24(4):455-e121.
产品手册
关联产品
-
Cabozantinib (S-mala...
Cabozantinib (XL184) is a potent, multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
-
8-O-Acetylshanzhisid...
8-O-Acetylshanzhiside methylester has potential against cerebral ischemic injury, and its protective effect on oxygen-glucose deprivation-induced injury might be due to the suppression of intracellular Ca2+ elevation and caspase-3 activity.
-
Bucillamine
Bucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.
